Insight certainty 3/5 debate potential 2/5

Kluz: 3:1 LTV-to-CAC ratio is the diligence sweet spot

Thomas Kluz · Strategic Corporate Venture Capital in Automotive, Healthcare, and Climate Tech with Niterra Ventures · Jul 25, 2025 · at 29:06

Thomas Kluz, Head of Investments at Niterra Ventures, discusses key unit economics and financial diligence benchmarks evaluated in prospective startup investments.

0:00 / 0:17exact quote · 17.4s
720p mp4 · rendered on demand · StarZero watermark
“I think three to one LTV to CAC seems to be kind of a sweet spot. I, that's kind of sometimes aspirational. A few of our portfolio companies have seen six to one, which is, I think outstanding. But that's the general sort of benchmark that we look for.”

quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →

More from Thomas Kluz

Insight
Kluz: Financial returns are easier to generate than strategic corporate value
“I think it's easier to generate cash on cash returns purely off good investments than it is to do financial returns. And find strategic value in companies.”
Thomas Kluz Jul 25, 2025 ▶ 15:42 Strategic Corporate Venture Capital in Automotive, Healthcare, and Climate Tech with Niterra Ventures
Disclosure
Kluz: Niterra Ventures does not require business unit alignment for deals
“So because our job is to drive new core assets which are effectively non-core, we don't need business unit alignment. But we do need a there on how is this going to create a new revenue stream for Natera in the future.”
Thomas Kluz Jul 25, 2025 ▶ 17:34 Strategic Corporate Venture Capital in Automotive, Healthcare, and Climate Tech with Niterra Ventures
Insight
Kluz: Unique tech without paying customers is a project, not a business
“If I don't see evidence that people are paying you money consistently and repeatedly, right? I'm going to have a hard time believing that you're doing something That maybe you're doing something no one else can do, but if no one's paying you for it, that's not…”
Thomas Kluz Jul 25, 2025 ▶ 27:04 Strategic Corporate Venture Capital in Automotive, Healthcare, and Climate Tech with Niterra Ventures
Opinion
Kluz: Advanced wound care is woefully underfunded in healthcare
“On the healthcare side we were very active in advanced wound care. This is just an area that we're, we think is woefully underfunded.”
Thomas Kluz Jul 25, 2025 ▶ 4:15 Strategic Corporate Venture Capital in Automotive, Healthcare, and Climate Tech with Niterra Ventures
Insight
Kluz: Career investors often forget founders have businesses to run
“I think when, you know, investors, sometimes life, lifetime investors never been on the operational side, I've noticed tend to kind of lose sight what the operator's kind of going through, right? The operator has, You know, day to day responsibility for the bu…”
Thomas Kluz Jul 25, 2025 ▶ 9:53 Strategic Corporate Venture Capital in Automotive, Healthcare, and Climate Tech with Niterra Ventures
Assertion Partly supported
Kluz: Niterra generates over $1B in annual free cash flow
“You know, Natera as a mothership generates about a billion plus in free cashflow every year. It's a very healthy business, very high margin business. Doing record earnings per share at this juncture and continues to get better.”
Thomas Kluz Jul 25, 2025 ▶ 11:51 Strategic Corporate Venture Capital in Automotive, Healthcare, and Climate Tech with Niterra Ventures
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 100 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.